Skip to main content
. 2023 Jan 17;12(3):348. doi: 10.3390/cells12030348

Figure 3.

Figure 3

Impact of ob-ASCs on cancer progression. Ob-ASCs are able to migrate towards the tumor site, differentiate into carcinoma-associated fibroblasts (CAFs), and secrete pro-tumorogenic soluble factors. This may result in cancer progression with increased tumor growth, neo-angiogenesis, invasiveness, and/or epithelial mesenchymal transition (EMT).